secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001654954-24-001022
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv reports FY2023 revenue $17.0M, net income $1.3M, declares special dividend $0.075/share
--------------------------------------------------------------------------------

- Revenue of $17.0M, down $2.4M YoY; net income of $1.3M, up $0.3M YoY.
- Gross profit margin improved 4.6 percentage points compared to last year.
- Special dividend of $0.075/share declared; payable Feb 15, 2024 to holders of record Jan 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424001022/0001654954-24-001022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424001022/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-001022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer